Lord’s Mark Industries, a leading diversified business group, has launched a new wholly owned subsidiary - Lord’s Mark Microbiotech - to champion Genome Testing in India with their first online lab. The new subsidiary has been established as a part of celebrations to mark the successful completion of 25 years of excellence in business by Lord’s Mark Industries.
Speaking on occasion, Mr Sachidanand Upadhyay, Founder of Lord’s Mark Industries, said, “Genome testing is an exciting new area with the potential to revolutionise healthcare in India. In this context, it is a matter of great pride that the launch of this new subsidiary coincides with the completion of 25 years of excellence in business by Lord’s Mark Industries. Lord’s Mark Microbiotech will focus on preventive Genomic testing for early detection, screening, and personalised interventions for diseases such as cancer, cardiovascular disorders, diabetes, or hereditary condition.”
Mr. Subodh Gupta, CEO of Lord’s Mark Microbiotech Private Limited, said, “We already have the technology for Genome testing. With the new subsidiary, we will focus on preventive Genomic testing for early detection, screening, and personalised interventions. The focus will also be on pharmacogenomics which can help optimise drug selection and dosages.”